Oxidative stress and post-transplant hypertension in pediatric kidney-transplanted patients

Journal of Pediatrics

Volumn 149, Issue 1, 2006, Pages 53-57

  Calò, Lorenzo A ^a   Dall'Amico, Roberto ^a   Pagnin, Elisa ^a   Bertipaglia, Lara ^a   Zacchello, Graziella ^a   Davis, Paul A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HEME OXYGENASE 1; PROTEIN DERIVATIVE; PROTEIN P22; PROTEIN P22PHOX; RNA; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HYPERTENSION; HYPOTHESIS; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; MONONUCLEAR CELL; ORGAN INJURY; OXIDATIVE STRESS; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SCHOOL CHILD; SIGNAL TRANSDUCTION;

ADOLESCENT; ANTIOXIDANTS; COPPER; FEMALE; GENE EXPRESSION; HEME OXYGENASE-1; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; NADPH OXIDASE; OXIDATIVE STRESS; RNA, MESSENGER;

EID: 33746123832     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.02.004     Document Type: Article

References (27)

1. First M.R., Neylan J.F., Rocher L.L., and Tejani A. Hypertension after renal transplantation. J Am Soc Nephrol 4 suppl (1994) S30-S36
2. Zeier M., Mandelbaum A., and Ritz E. Hypertension in the transplanted patient. Nephron 80 (1998) 257-268
3. Pochet J.M., Pirson Y., and Van Ypersele De Strihou C. Is post renal transplantation hypertension more severe or more frequent on cyclosporine than on conventional therapy?. Nephrol Dial Transplant 4 (1989) 507-510
4. Remuzzi G., and Perico N. Protecting single-kidney allografts from long-term functional deterioration. J Am Soc Nephrol 9 (1998) 1321-1332
5. Paul L.C. Chronic allograft nephropathy. an update. Kidney Int 56 (1999) 783-793
6. Diederich D., Skopec J., Diederich A., and Dai F.X. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension 23 part 2 (1994) 957-961
7. Lopez-Ongil S., Hernandez-Perera O., Navarro-Antolin J., Perez de Lema G., Rodriguez-Puyol M., Lamas S., et al. Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of cNOS in vascular endothelial cells. Br J Pharmacol 124 (1998) 447-454
8. Navarro-Antolin J., Hernandez-Perera O., Lopez-Ongil S., Rodriguez-Puyol M., Rodriguez-Puyol D., and Lamas S. CsA and FK506 up regulate cNOS expression. role of reactive oxygen species and AP-1. Kidney Int Suppl 68 (1998) S20-S24
9. Mitsnefes M.M., and Portman R.J. Ambulatory blood pressure monitoring in pediatric renal transplantation. Pediatr Transplant 7 (2003) 86-92
10. Calò L., Semplicini A., Davis P.A., Bonvicini P., Cantaro S., Rigotti P., et al. Cyclosporin-induced endothelial disfunction and hypertension. are nitric oxide system abnormality and oxidative stress involved?. Transplant Int 13 Suppl 1 (2000) S413-S418
11. Nath K.A., Grande J., Croatt A., Haugen J., Kim Y., and Rosenberg M.E. Redox regulation of renal DNA synthesis, transforming growth factor-beta-1 and collagen gene expression. Kidney Int 53 (1998) 367-381
12. Griendling K.K., Soresen D., and Ushio-Fukai M. NAD(P)H oxidase. role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
13. Calo L.A., Davis P.A., Giacon B., Pagnin E., Sartori M., Riegler P., et al. Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension. effect of ramipril. J Cardiovasc Pharmacol 40 (2002) 625-631
14. Maines M.D. The heme oxygenase system. a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37 (1997) 517-554
15. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., and Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 235 (1987) 1043-1046
16. Immenschuh S., and Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 60 (2000) 1121-1128
17. Turi S., Friedman A., Bereczki C., Papp F., Kovacs J., Karg E., et al. Oxidative stress in juvenile essential hypertension. J Hypertens 21 (2003) 145-152
18. Calò L.A., Pagnin E., Davis P.A., Sartori M., and Semplicini A. Oxidative stress-related factors in Bartter's and Gitelman's syndromes. relevance for angiotensin II signalling. Nephrol Dial Transplant 18 (2003) 1518-1525
19. Calo L., Giacon B., Davis P.A., Pagnin E., Piccin A., Riegler P., et al. Oxidative stress and TGF-beta in kidney-transplanted patients with cyclosporin-induced hypertension. effect of carvedilol and nifedipine. Clin Nephrol 58 (2002) 103-110
20. Bellomo G., Perrugini C., and Bagnati M. Biochemical markers of lipoprotein oxidation. (Abstract). Clin Chem Lab Med 36 (1998) A41
21. Abe J., and Berk B.C. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med 8 (1998) 59-64
22. Hilgers K.F. Monocytes/macrophages in hypertension. J Hypertens 20 (2002) 593-596
23. Yasunari K., Maeda K., Nakamura M., and Yoshikawa J. Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 39 (2002) 777-780
24. Griendling K.K., and FitzGerald G.A. Oxidative stress and cardiovascular injury, II. animal and human studies. Circulation 108 (2003) 2034-2040
25. Griendling K.K., Sorescu D., Lassègue B., and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20 (2000) 2175-2183
26. Touyz R.M. Role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 5 (2003) 155-164
27. Fukui T., Ishizaka N., Rajagopalan S., Laursen J.B., Capers IV Q., Taylor W.R., et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80 (1997) 45-51